We are live on ! Find out more
WLKP icon

Westlake Chemical Partners

46 hedge funds and large institutions have $388M invested in Westlake Chemical Partners in 2019 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 20 increasing their positions, 11 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

82% more repeat investments, than reductions

Existing positions increased: 20 | Existing positions reduced: 11

59% more call options, than puts

Call options by funds: $2.27M | Put options by funds: $1.42M

17% more first-time investments, than exits

New positions opened: 7 | Existing positions closed: 6

8% more capital invested

Capital invested by funds: $357M → $388M (+$30.1M)

0% more funds holding

Funds holding: 4646 (0)

4.13% less ownership

Funds ownership: 49.03%44.9% (-4.1%)

Holders
46
Holders Change
Holders Change %
0%
% of All Funds
1%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
7
Increased
20
Reduced
11
Closed
6
Calls
$2.27M
Puts
$1.42M
Net Calls
+$843K
Net Calls Change
+$1.93M
Name Holding Trade Value Shares
Change
Change in
Stake
Invesco
1
Invesco
Georgia
$157M +$147M +6,373,112 New
EIP
2
Energy Income Partners
Connecticut
$41.9M +$268K +11,604 +0.7%
Janus Henderson Group
3
Janus Henderson Group
United Kingdom
$41.5M -$3.04M -131,757 -7%
UBS Group
4
UBS Group
Switzerland
$24.5M +$2.36M +102,256 +11%
Morgan Stanley
5
Morgan Stanley
New York
$17.4M +$3.2M +138,617 +24%
TCA
6
Tortoise Capital Advisors
Kansas
$17.2M
ClearBridge Investments
7
ClearBridge Investments
New York
$15M +$4.31M +186,915 +44%
DPIM
8
Duff & Phelps Investment Management
Illinois
$13M -$2.19M -95,000 -15%
TA
9
Tiedemann Advisors
New York
$9.83M +$118K +5,110 +1%
Arrowstreet Capital
10
Arrowstreet Capital
Massachusetts
$7.61M +$2.96M +128,311 +71%
Goldman Sachs
11
Goldman Sachs
New York
$7.3M +$3.51M +151,944 +105%
Citigroup
12
Citigroup
New York
$5.58M +$231K +10,000 +5%
SCA
13
Salient Capital Advisors
Texas
$4.03M -$8.45M -366,300 -69%
Acadian Asset Management
14
Acadian Asset Management
Massachusetts
$3.59M +$273K +11,809 +9%
California Public Employees Retirement System
15
California Public Employees Retirement System
California
$2.58M -$91.8K -3,979 -4%
William Blair & Company
16
William Blair & Company
Illinois
$2.43M +$300 +13 +0%
Parallax Volatility Advisers
17
Parallax Volatility Advisers
California
$2.37M +$2.23M +96,447 New
MIM
18
MetLife Investment Management
New Jersey
$1.94M
SCM
19
Shapiro Capital Management
Georgia
$1.42M
VanEck Associates
20
VanEck Associates
New York
$1.39M +$29K +1,255 +2%
Deutsche Bank
21
Deutsche Bank
Germany
$1.24M +$609K +26,374 +109%
Bank of Montreal
22
Bank of Montreal
Ontario, Canada
$1.23M
NC
23
NBW Capital
Massachusetts
$1.11M +$1.04M +45,022 New
Russell Investments Group
24
Russell Investments Group
United Kingdom
$977K -$30K -1,300 -3%
Wells Fargo
25
Wells Fargo
California
$846K -$428K -18,526 -35%

WLKP Hedge Fund Activity: Q2 2019 in Review

46 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in Westlake Chemical Partners (WLKP) for Q2 2019, worth a combined $388M — up 8.4% from $357M a quarter earlier.

Buyers outnumbered sellers: 7 funds opened new WLKP positions and 6 closed out — a net gain of 1 holder — while 20 added to existing stakes and 11 trimmed.

The largest buyer was Invesco, opening a new position worth an estimated $147M. The largest seller was Harvest Fund Advisors, exiting entirely with an estimated $14M sold.

  • 46 institutional investors held Westlake Chemical Partners (WLKP) as of Q2 2019, unchanged from Q1 2019.
  • Funds reported $388M of Westlake Chemical Partners stock for Q2 2019, up 8.4% quarter-over-quarter.
  • 7 funds opened new Westlake Chemical Partners positions in Q2 2019 and 6 closed out, a net change of +1 holder.
  • The largest Westlake Chemical Partners buyer in Q2 2019 was Invesco, an estimated $147M added.
  • The largest Westlake Chemical Partners seller in Q2 2019 was Harvest Fund Advisors, an estimated $14M sold.

Based on aggregated 13F filings for Q2 2019.